Drug Type Gene therapy |
Synonyms LGMD2D therapy(Atamyo Therapeutics) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sarcoglycanopathies | Preclinical | FR | Atamyo Therapeutics SASStartup | 09 Aug 2022 |